4-AcO-DPT

From Wikipedia, the free encyclopedia

Other namesDepracetin
ATC code
  • None
4-AcO-DPT
Clinical data
Other namesDepracetin
Routes of
administration
Oral
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Identifiers
  • 3-[2-(diethylamino)ethyl]-1H-indol-4-yl acetate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC18H26N2O2
Molar mass302.418 g·mol−1
3D model (JSmol)
  • CCCN(CCC)CCC1=CNC2=C1C(=CC=C2)OC(=O)C

4-AcO-DPT, also known as 4-acetoxy-N,N-dipropyltryptamine or as depracetin, is a psychedelic drug of the tryptamine family related to 4-AcO-DMT. It has been sold as a designer drug.[1] It is an ester of 4-HO-DPT, a psychedelic tryptamine that was first synthesized by Alexander Shulgin. Anecdotal reports indicate that 4-AcO-DPT exerts psychoactive effects in humans, however the pharmacology of 4-AcO-DPT has not been examined.[citation needed] It has been identified in illicit products in Japan.[2]

Interactions

Chemistry

Analogues

Analogues of 4-AcO-DPT include dipropyltryptamine (DPT), 4-HO-DPT (deprocin), 4-AcO-DMT (psilacetin), 4-AcO-DET (ethacetin), 4-AcO-DiPT (ipracetin), 4-AcO-MET (metacetin), 4-AcO-MPT, and 4-AcO-MiPT (mipracetin), among others.

Society and culture

Canada

4-AcO-DPT is not a controlled substance in Canada as of 2025.[3]

See also

References

Related Articles

Wikiwand AI